Elanco Animal Health Inc

자세한 내용은 Elanco Animal Health Inc 회사

Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

회사 정보

종목 코드 ELAN

회사 이름Elanco Animal Health Inc

상장일Sep 20, 2018

CEOMr. Jeffrey N. (Jeff) Simmons

직원 수9000

유형Ordinary Share

회계 연도 종료Sep 20

주소2500 Innovation Way N

도시GREENFIELD

증권 거래소NYSE Consolidated

국가United States of America

우편 번호46140-9163

전화18773526261

웹사이트https://www.elanco.com/

종목 코드 ELAN

상장일Sep 20, 2018

CEOMr. Jeffrey N. (Jeff) Simmons

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

79.40K

--

Mr. Paul S. Herendeen

Independent Director

74.50K

--

Mr. James Meer

Senior Vice President, Chief Accounting Officer

62.55K

-1.82%

Ms. Shiv O'Neill

Executive Vice President, General Counsel, Corporate Secretary

53.92K

+100.82%

이름

이름/직위

직위

주식 보유

변동

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

사업별USD

이름

수익

비율

Pet Health

635.00M

53.23%

Farm Animal

546.00M

45.77%

Contract Manufacturing

12.00M

1.01%

지역별USD

이름

수익

비율

International

639.00M

53.56%

United States

554.00M

46.44%

사업별

지역별

사업별USD

이름

수익

비율

Pet Health

635.00M

53.23%

Farm Animal

546.00M

45.77%

Contract Manufacturing

12.00M

1.01%

주식 보유 통계

마지막 업데이트: Fri, May 16

주주

주주 유형

주주

비율

Dodge & Cox

16.70%

PRIMECAP Management Company

10.11%

The Vanguard Group, Inc.

9.69%

Fidelity Management & Research Company LLC

7.71%

Black Creek Investment Management, Inc.

4.44%

Other

51.35%

주주

비율

Dodge & Cox

16.70%

PRIMECAP Management Company

10.11%

The Vanguard Group, Inc.

9.69%

Fidelity Management & Research Company LLC

7.71%

Black Creek Investment Management, Inc.

4.44%

Other

51.35%

주주 유형

주주

비율

Investment Advisor

63.16%

Investment Advisor/Hedge Fund

32.92%

Hedge Fund

3.35%

Individual Investor

1.08%

Research Firm

1.01%

Sovereign Wealth Fund

0.79%

Pension Fund

0.77%

Bank and Trust

0.44%

Family Office

0.11%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

879

514.22M

103.54%

-39.32M

2025Q1

974

511.32M

102.96%

-71.50M

2024Q4

996

503.77M

101.85%

-80.73M

2024Q3

1000

494.48M

100.04%

-96.31M

2024Q2

1034

494.94M

100.16%

-92.98M

2024Q1

1051

494.01M

100.22%

-99.13M

2023Q4

1048

492.96M

100.04%

-103.67M

2023Q3

1055

493.54M

100.18%

-93.98M

2023Q2

1067

490.17M

99.54%

-75.35M

2023Q1

1071

498.03M

101.25%

-46.19M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Dodge & Cox

82.92M

16.7%

-260.08K

-0.31%

Mar 31, 2025

PRIMECAP Management Company

50.22M

10.11%

-941.63K

-1.84%

Mar 31, 2025

The Vanguard Group, Inc.

48.14M

9.69%

-437.73K

-0.90%

Mar 31, 2025

Fidelity Management & Research Company LLC

38.30M

7.71%

+9.79M

+34.35%

Mar 31, 2025

Black Creek Investment Management, Inc.

22.04M

4.44%

+1.61M

+7.87%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

20.46M

4.12%

+2.56M

+14.32%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

20.06M

4.04%

-618.85K

-2.99%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

15.98M

3.22%

+292.65K

+1.87%

Mar 31, 2025

Fidelity Institutional Asset Management

15.55M

3.13%

+3.83M

+32.70%

Mar 31, 2025

Shapiro Capital Management LLC

12.33M

2.48%

-24.38K

-0.20%

Mar 31, 2025

14.015USD

Elanco Animal Health Inc

14.015

개요

회사

금융